- Home
- NOTE vs GNTA Comparison
NOTE vs GNTA Comparison
Compare NOTE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- GNTA
- Stock Information
- Founded
- NOTE 2013
- GNTA 2014
- Country
- NOTE United States
- GNTA Italy
- Employees
- NOTE N/A
- GNTA N/A
- Industry
- NOTE EDP Services
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NOTE Technology
- GNTA Health Care
- Exchange
- NOTE Nasdaq
- GNTA Nasdaq
- Market Cap
- NOTE 63.9M
- GNTA 59.7M
- IPO Year
- NOTE N/A
- GNTA 2021
- Fundamental
- Price
- NOTE $4.00
- GNTA $3.01
- Analyst Decision
- NOTE Strong Buy
- GNTA
- Analyst Count
- NOTE 4
- GNTA 0
- Target Price
- NOTE $29.25
- GNTA N/A
- AVG Volume (30 Days)
- NOTE 257.5K
- GNTA 1.9M
- Earning Date
- NOTE 11-12-2025
- GNTA 01-01-0001
- Dividend Yield
- NOTE N/A
- GNTA N/A
- EPS Growth
- NOTE N/A
- GNTA N/A
- EPS
- NOTE N/A
- GNTA N/A
- Revenue
- NOTE $109,683,000.00
- GNTA N/A
- Revenue This Year
- NOTE N/A
- GNTA N/A
- Revenue Next Year
- NOTE $4.61
- GNTA N/A
- P/E Ratio
- NOTE N/A
- GNTA N/A
- Revenue Growth
- NOTE N/A
- GNTA N/A
- 52 Week Low
- NOTE $3.80
- GNTA $2.33
- 52 Week High
- NOTE $24.36
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- NOTE 41.52
- GNTA 47.53
- Support Level
- NOTE $4.15
- GNTA $2.33
- Resistance Level
- NOTE $4.54
- GNTA $10.00
- Average True Range (ATR)
- NOTE 0.30
- GNTA 0.62
- MACD
- NOTE -0.13
- GNTA -0.02
- Stochastic Oscillator
- NOTE 1.81
- GNTA 8.87
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.